| 2022-08-24 | Sale | Voyager Therapeutics, Inc. VYGR | 200,000 0.5261% | $6.22 | $1.24M | +25.57% | ||
| 2022-08-16 | Sale | Voyager Therapeutics, Inc. VYGR | 128,456 0.3314% | $6.04 | $775,874 | +24.18% | ||
| 2022-08-12 | Sale | Voyager Therapeutics, Inc. VYGR | 135,808 0.3509% | $6.04 | $820,280 | +23.72% | ||
| 2022-06-08 | Sale | Revolution Medicines, Inc. RVMD | 419,901 0.5834% | $20.25 | $8.5M | +15.65% | ||
| 2017-10-04 | Sale | CytomX Therapeutics, Inc. CTMX | 10 percent owner | 49,554 0.1352% | $24.34 | $1.21M | +5.89% | |
| 2017-09-19 | Sale | CytomX Therapeutics, Inc. CTMX | 10 percent owner | 40,000 0.1091% | $18.00 | $720,000 | +36.82% | |
| 2017-06-29 | Sale | CytomX Therapeutics, Inc. CTMX | 10 percent owner | 30,000 0.0817% | $16.00 | $480,000 | +38.58% | |
| 2014-09-12 | Sale | bluebird bio, Inc. BLUE | 76,000 0.268% | $36.59 | $2.78M | +220.38% | ||
| 2014-09-11 | Sale | bluebird bio, Inc. BLUE | 174,000 0.6192% | $36.52 | $6.35M | +222.38% | ||
| 2014-01-21 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 250,000 1.0305% | $23.91 | $5.98M | +42.94% | |
| 2014-01-17 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 14,000 0.0586% | $23.96 | $335,440 | +44.47% | |
| 2014-01-16 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 33,000 0.1368% | $24.02 | $792,660 | +42.62% | |
| 2014-01-15 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 260,000 1.0571% | $22.14 | $5.76M | +51.31% | |
| 2014-01-14 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 270,000 1.111% | $21.91 | $5.92M | +54.35% | |
| 2014-01-13 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 45,000 0.1876% | $21.80 | $981,000 | +57.07% | |
| 2014-01-10 | Sale | bluebird bio, Inc. BLUE | director, 10 percent owner | 25,000 0.1044% | $21.98 | $549,500 | +55.94% |